Why the study?
Do ACE inhibitors (captopril, quinapril) or ARBs (losartan) prevent atherosclerosis and preserve vascular function in a rabbit model on a high-cholesterol diet?
Do ACE inhibitors (captopril, quinapril) or ARBs (losartan) prevent atherosclerosis and preserve vascular function in a rabbit model on a high-cholesterol diet?
In a hypercholesterolemic rabbit model, ACE inhibitors and ARBs similarly reduced atherogenesis, but ACE inhibitors were superior in preserving vascular endothelial function.
Answers are grounded in this paper and cite their sources.
Preclinical superiority of ACEIs over ARBs for endothelial preservation warrants clinical caution; leaves open translation to human atherosclerosis.
BACKGROUND: Both angiotensin-converting enzyme inhibitors (ACE-I(s)) and angiotensin receptor blockers (ARB(s)) provide vascular protection. This study was designed to compare ACE-I(s) with widely differing tissue affinity (captopril and quinapril) and an ARB (losartan) on vascular protection against the adverse effects of high cholesterol. METHODS AND RESULTS: Forty-two New Zealand rabbits on a 0.5% cholesterol diet were randomized into control, captopril (10 mg/kg/d), quinapril (0.3 mg/kg/d), and losartan (8 mg/kg/d) groups for 14 weeks. Captopril, quinapril, and losartan significantly attenuated aortic lipid lesions (P=0.001). Captopril and quinapril were more effective than losartan in preserving vascular relaxation. CONCLUSIONS: Captopril, quinapril, and losartan had similar protective effects against atherogenesis. Captopril and quinapril were more effective than losartan in preserving vascular function. Increased bradykinin by ACE inhibition may be responsible for this improved vascular endothelial function.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: